EOLS
Evolus Inc
Price:  
7.63 
USD
Volume:  
472,060.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EOLS WACC - Weighted Average Cost of Capital

The WACC of Evolus Inc (EOLS) is 7.6%.

The Cost of Equity of Evolus Inc (EOLS) is 7.30%.
The Cost of Debt of Evolus Inc (EOLS) is 8.95%.

Range Selected
Cost of equity 6.10% - 8.50% 7.30%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 7.00% - 10.90% 8.95%
WACC 6.3% - 9.0% 7.6%
WACC

EOLS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.65
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 8.50%
Tax rate 0.10% 0.20%
Debt/Equity ratio 0.25 0.25
Cost of debt 7.00% 10.90%
After-tax WACC 6.3% 9.0%
Selected WACC 7.6%

EOLS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for EOLS:

cost_of_equity (7.30%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.5) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.